Viewing Study NCT01685892


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-02-24 @ 2:09 PM
Study NCT ID: NCT01685892
Status: COMPLETED
Last Update Posted: 2020-01-10
First Post: 2012-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module